Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone plus tamoxifen before surgery for early hormone receptor-positive breast cancer in premenopausal women
ISRCTN23662758Phase 2Completed
- Sponsor
- University of Liverpool
- Start
- Jun 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial in breast cancer comparing Tamoxifen plus micronised progesterone with Tamoxifen alone (2 arms). Primary endpoint: Change in Ki67 proliferation index. Started Jun 2018; status: completed.
02
Drugs
progesteronetamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN23662758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN23662758.